Form 4: Omega Healthcare Investors Director Receives Annual Stock Compensation Grant

Kevin J. Jacobs, a Director at Omega Healthcare Investors Inc., was granted 7,114 shares of common stock as compensation, valued at $37.6 per share, which will vest in approximately one year.

Summary

• Kevin J. Jacobs, a Director of Omega Healthcare Investors Inc. (OHI), acquired 7,114 shares of common stock.
• The transaction occurred on June 6, 2025, at a price of $37.6 per share.
• This acquisition represents director compensation through a Restricted Stock Grant Award Agreement.
• The granted shares will vest on the date of the Company's 2026 Annual Meeting of Shareholders, approximately one year from the grant date.
• Following this transaction, Kevin J. Jacobs beneficially owns 40,810 shares of OHI common stock.

Sentiment

Score: 6

Explanation: The document reports a routine director compensation grant in the form of restricted stock, which is a neutral to slightly positive event as it aligns director interests with shareholders. It does not contain any significant positive or negative news regarding company operations or financial performance.

Positives

• The grant of restricted stock aligns the director's interests with those of shareholders, as the value of their compensation is tied to the company's stock performance.

Negatives

• No direct negative financial implications are apparent from this routine compensation grant.

Future Outlook

The restricted stock grant is set to vest around the time of the Company's 2026 Annual Meeting of Shareholders, indicating a future alignment of director incentives with long-term company performance.

Industry Context

This transaction is a standard practice for compensating directors in publicly traded companies, including Real Estate Investment Trusts (REITs) like Omega Healthcare Investors, often using equity to align leadership interests with shareholder value.

Comparison to Industry Standards

• Director compensation through restricted stock grants is a common practice across various industries, including healthcare REITs.
• While specific compensation amounts vary by company size and performance, the mechanism of equity-based awards is consistent with industry benchmarks for aligning director incentives with long-term shareholder value.
• No specific comparable companies or projects are detailed in this filing.

Corporate Governance

Related Party Transactions

• The restricted stock grant to Kevin J. Jacobs, a director, constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with long-term shareholder value through equity ownership.

Next Steps

• The restricted stock grant will vest on the date of Omega Healthcare Investors Inc.'s 2026 Annual Meeting of Shareholders.

Key Dates

Keywords

Omega Healthcare Investors, OHI, Form 4, Insider Transaction, Director Compensation, Restricted Stock Grant, Equity Compensation, Kevin J. Jacobs, Healthcare REIT